Position in INCY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$133,934,612
+$39,441,051 QoQ
Shares Held
1,181,498
+17.7% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#33
of 854 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amundi holds $2,427,056,148 across 70 Biotechnology names. INCY ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,546,509 | $768,197,412 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,013,540 | $631,982,729 | |
| 3 | RPRX |
Royalty Pharma plc
|
3,723,864 | $208,797,052 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
617,471 | $185,877,294 | |
| 5 | INCY |
Incyte Corp
This page
|
1,181,498 | $133,934,612 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,827,241 | $129,094,576 | |
| 7 | MRNA |
Moderna, Inc.
|
888,779 | $62,241,193 | |
| 8 | ARGX |
Argenx SE
|
65,122 | $60,418,237 |
All Filings in INCY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,934,612 | 1,181,498 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $94,493,561 | 1,003,969 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $76,466,351 | 774,186 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $42,500,919 | 501,131 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $41,762,324 | 613,250 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $31,003,413 | 512,030 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $46,301,072 | 670,350 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $34,366,642 | 519,919 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $42,416,841 | 699,717 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $160,738,628 | 2,821,461 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $191,666,784 | 3,052,505 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $109,231,281 | 1,890,796 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $85,921,368 | 1,380,263 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $121,768,948 | 1,684,917 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $103,554,805 | 1,289,278 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $119,849,704 | 1,798,465 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,715,045 | 404,305 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $22,515,089 | 283,494 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $20,931,254 | 285,167 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,429,860 | 297,032 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $22,229,245 | 264,225 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||